🇺🇸 FDA
Pipeline program

Ivarmacitinib tablet

2025-200

Unknown small_molecule active

Quick answer

Ivarmacitinib tablet for Polymyalgia Rheumatics (PMR) is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Polymyalgia Rheumatics (PMR)
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials